Combination Therapy Explored for Psoriasis and Obesity in Phase 3b Study

Plaque psoriasis is a chronic, immune-mediated inflammatory skin condition characterized by red, scaly patches, often associated with significant comorbidities. A common and impactful comorbidity is obesity, which can exacerbate psoriasis severity, reduce treatment efficacy, and increase the risk of other metabolic diseases. While effective treatments for plaque psoriasis exist, they typically do not address the underlying metabolic dysfunction. This Phase 3b study aims to address this critical gap by investigating whether a combined therapeutic approach, targeting both psoriasis and obesity, can yield superior outcomes compared to psoriasis treatment alone.